Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma.
Phase of Trial: Phase II
Latest Information Update: 15 Mar 2017
At a glance
- Drugs Panitumumab (Primary) ; Capecitabine; Gemcitabine; Oxaliplatin
- Indications Cholangiocarcinoma
- Focus Therapeutic Use
- Acronyms GOX-P
- 09 Mar 2017 Status changed from active, no longer recruiting to completed.
- 24 Mar 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 06 Dec 2013 Planned end date changed from 1 Jul 2014 to 1 Jul 2015 as reported by ClinicalTrials.gov.